Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-dopa vs Dopamine Agonists Monotherapy After STN DBS in Parkinson's Disease
NCT02347059Phase 2Unknown
- Sponsor
- University of Toronto
- Start
- Jan 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of levodopa, pramipexole and ropinirole in Parkinson's disease (PD) (2 arms), sponsored by University of Toronto. Primary endpoint: Non-motor Symptoms Scale at 3 months. Status: unknown.
02
Drugs
levodopapramipexoleropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02347059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347059.